Table 2.
Post-transplant outcomes according to donor sex/parity.
| Donor sex/ parity | Probability (%) | 95% CI | P | |
|---|---|---|---|---|
| Grade III-IV aGVHD | Parous female | 55.27 | 43.96-69.00 | 0.00 |
| Male | 11.34 | 8.88-14.00 | ||
| Nulliparous female | 10.84 | 7.58-16.00 | ||
| Extensive cGVHD | Parous female | 64.32 | 50.67-82.00 | 0.00 |
| Male | 15.52 | 12.38-19.00 | ||
| Nulliparous female | 13.65 | 9.57-19.00 | ||
| GRFS | Parous female | 11.48 | 7.19-16.87 | 0.000 |
| Male | 41.41 | 37.32-45.43 | ||
| Nulliparous female | 36.01 | 30.17-41.87 | ||
| RI | Parous female | 21.26 | 14.22-31.77 | 0.00 |
| Male | 39.24 | 33.53-45.93 | ||
| Nulliparous female | 46.51 | 37.35-57.91 | ||
| OS | Parous female | 49.17 | 41.57-56.31 | 0.039 |
| Male | 56.32 | 52.12-60.29 | ||
| Nulliparous female | 48.61 | 42.48-54.45 |
aGVHD indicates acute graft-versus-host disease; cGVHD, chronic graft-versus-host disease; CI, confidence interval; CR2, second complete remission; GFRS, graft-versus-host disease free relapse free survival; OS, overall survival; RI, relapse incidence.